General Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ In Sirna Therapeutic DeliveryBy Healthcare Propulsion StaffOctober 13, 20260 Undecimal Bio (“Undecimal”), a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD…
